Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2625 to 2674 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1077\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1991\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5749.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5429.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05902\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1992\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 1; glvr-1; pit-1; gibbon ape leukemia virus receptor 1. [source:refseq;acc:nm\_005415]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1182\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1179\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 21 member 15 (organic anion transporter polypeptide-related protein 4) (oatp-rp4) (oatprp4). [source:swissprot;acc:q9h2y9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2965\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 23, member 2 (sodium-dependent vitamin c transporter 2) (hsvct2) (na(+)/l-ascorbic acid transporter 2) (yolk sac permease-like molecule 2) (nucleobase transporter-like 1 protein). [source:swissprot;acc:q9ugh3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1831\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 4; fatty acid transport protein 4. [source:refseq;acc:nm\_005094]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7274.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6961.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04492\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 5; very long-chain acyl-coa synthetase homolog 2; very long-chain acyl-coa synthetase-related protein; likely ortholog of mouse solute carrier family 27 (fatty acid transporter), member 5. [source:refseq;acc:nm\_012254]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7273.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6961.11\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04493\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 member 3; fatty acid transport protein 3. [source:refseq;acc:nm\_024330]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7273.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6961.19\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 35, member b1; udp-galactose transporter related. [source:refseq;acc:nm\_005827]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2496\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5684.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5534.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 36 member 1; proton / amino acid symporter; lysosomal amino acid transporter 1. [source:refseq;acc:nm\_078483]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
614\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 5 (iodide transporter), member 8; apical iodide transporter. [source:refseq;acc:nm\_145913]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1166\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7185.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6606.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1928\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7980.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7514.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1905\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7967.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7497.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
95\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3343.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2397.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
442\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7192.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6071.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5932.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02348\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1972\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 16. [source:swissprot;acc:p57768]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3108\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 17. [source:swissprot;acc:q15036]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2741\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5327.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5339.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00234\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 6 (traf4-associated factor 2). [source:swissprot;acc:q9unh7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2657\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5371.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5327.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00824\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1049\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
188\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28281\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sparc precursor (secreted protein acidic and rich in cysteine) (osteonectin) (on) (basement membrane protein bm-40). [source:swissprot;acc:p09486]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3062\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sparc-like protein 1 precursor (high endothelial venule protein) (hevin) (mast 9). [source:swissprot;acc:q14515]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2899\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
spartin; trans-activated by hepatitis c virus core protein 1. [source:refseq;acc:nm\_015087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2987\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
speckle-type poz protein. [source:swissprot;acc:o43791]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3031\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin alpha chain, brain (spectrin, non-erythroid alpha chain) (alpha-ii spectrin) (fodrin alpha chain). [source:swissprot;acc:q13813]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3038\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1602\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5605.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5232.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07142\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1601\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
968\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1334\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08018\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sperm tail protein shippo1; h-shippo 1. [source:refseq;acc:nm\_053280]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
69\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermidine synthase (ec 2.5.1.16) (putrescine aminopropyltransferase) (spdsy). [source:swissprot;acc:p19623]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1306\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5949.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5500.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0815\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermine synthase (ec 2.5.1.22) (spermidine aminopropyltransferase) (spmsy). [source:swissprot;acc:p52788]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3118\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6370.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5873.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08457\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
472\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
485\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1468\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5473.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spir-2 protein (fragment). [source:sptrembl;acc:q8wwl2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2879\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spliceosomal u5 snrnp-specific 15 kda protein (dim1 protein homolog) (thioredoxin-like u5 snrnp protein u5-15kd). [source:swissprot;acc:o14834]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
236\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5828.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4723.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1958\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5777.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5448.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06039\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/